WZB117 is primarily used in research settings to study glucose metabolism and cancer cell growth. It functions as an inhibitor of glucose transporter 1 (GLUT1), which is crucial for the uptake of glucose in cells. By blocking GLUT1, WZB117 helps researchers understand the role of glucose metabolism in cancer progression, as cancer cells often rely heavily on glucose for energy. This compound is particularly valuable in experiments aimed at exploring potential therapeutic strategies for targeting cancer metabolism. Additionally, WZB117 aids in investigating the metabolic adaptations of cells under glucose deprivation, providing insights into cellular survival mechanisms and potential vulnerabilities in cancer cells.